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Weaned rabbits were fed diets contaminated with 2 mg/kg diet T-2 toxin alone, or 10 mg/kg 
diet fumonisin B1 (FB1) alone, and both toxins in combination (2+10 mg / kg, resp.), as 
compared to a toxin free control diet. Samplings were performed after 4 weeks (blood and 
liver). Bodyweight of T-2-fed group was lower after 4 weeks; the liver weight was increased 
dramatically (3-fold of control). Liver total phospholipids (PL) provided slight alterations in 
the fatty acid (FA) composition; all three toxin treated groups showed decrease in palmitoleic 
acid (C16:1 n7) proportion. In the liver mitochondrial PL FA composition margaric acid 
(C17:0) proportion decreased in the separated toxin treatments, compared to the combined 
setting. Oleic acid (C18:1 n9) proportion was increased and arachidonic acid (C20:4 n6) was 
decreased in the by FB1-treated group, while docosapentaenoic acid (C22:5 n3) was decreased 
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in the separated treatments. The total monounsaturation was significantly higher in the FB1 
group’s mitochondrial PL FA profile. After 4 weeks, all toxin treatments decreased the blood 
plasma reduced glutathione and glutathione peroxidase activity, and FB1 increased the plasma 
sphinganine/sphingosine ratio. Both mycotoxins seem to cross the hepatocellular and the 
hepatic mitochondrial membrane, without drastic membrane disruption, as assessed from the 
PL FA composition, but inducing detectable lipid peroxidation. 
  




Mycotoxins are secondary metabolites of fungal (mold) metabolism with various biological 
activities, e.g. protein (T-2) or ceramide (Fumonisin B1, FB1) synthesis inhibition, but T-2 and 
FB1 in high concentrations and prolonged consumption are as well carcinogens (9,11, 13). 
Since most fungal strains produce single or multiple mycotoxins, their combined effects are 
nowadays in focus (12).  
T-2 toxin is a trichothecene, produced by Fusarium species, occurring mostly in corn and 
further cereals. T-2 toxin is metabolized (hydrolyzed to HT-2) after ingestion, yielding 
multiple metabolites with known or less known toxicity and membrane association capability 
(9). Their mode of toxic action is rather divergent, as the inhibition of protein synthesis 
(specifically in eukaryotes) and inhibition of DNA synthesis (9), or the disruption of the 
mitochondrial electron transport system (26), augmented lipid peroxidation, affecting 
ultimately cell membrane integrity. According to Ngampongsa et al. (26), the ATP-linked 
oxygen consumption rate of cardiomyocyte mitochondria is compromised by T-2 toxin, which 




 ATPase activity 
(the rate of ATP breakdown) was markedly lowered by T-2 toxin (33). It was established that 
in the rat liver T-2 toxin inhibits mitochondrial electron transport system, concluding that 
mitochondria are a possible hepatic targets of T-2 toxin action (27). It is important to add that 
even in embryonic stem cells (being pluripotent!), T-2 toxin induced apoptosis via a reactive 
oxygen species mediated mitochondrial pathway (14). In summary, it is proven that T-2 toxin 
crosses the hepatic cellular and subcellular membranes and disrupts ATP production in 
mitochondria (28). An essential addition is that hepatic subcellular distribution of labelled 
[3H]
T-2 toxin revealed immediate association to the plasma membrane and a concomitant 
association to the membranes of other cellular compartments, including mitochondria (28). 
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Anyhow, T-2 toxin is less known considering its membrane disruptor effect exerted during its 
membrane transitory movement, on which the present study was focused. The question is 
even more intriguing taking the solubility of pure T-2 toxin into account, namely it is only 
weakly water soluble (3).  
Molecular - compositional changes underlying hepatic membrane lipid alterations 
(alteration of the lipid profile of phospholipid classes in the microsomal, the nuclear and the 
cellular membranes) caused by FB1 were partly elucidated when feeding rats a drastically 
toxic, cancer promoting toxin level (250 mg/kg feed) (6). In the same study FB1 altered lipid 
constituent proportions, in particular phosphatidylethanolamines (PE) were significantly 
increased in the mitochondrial and even in plasma membrane fractions. The fatty acid profile 
of the main polar lipid fractions (i.e. P-choline and PE) showed a decrease in polyunsaturated 
(especially C20:4 n6, arachidonic acid)/saturated (P/S) FA ratio, suggesting a less fluid 
membrane state. The decreased polyunsaturated fatty acid levels in PC along with a marked 
elevation of oleic (C18:1 n9) and linoleic (C18:2 n6) acids were indicative of an impaired Δ6 
desaturase activity. Authors concluded that FB1 disrupts sphingolipid, phospholipid (the polar 
lipid fractions interaction with a polar toxin molecule), cholesterol and FA metabolism in the 
liver, in a manner to decrease membrane fluidity (ultimately leading to apoptosis). 
Arachidonic acid has a profound role in this, namely the outer plasma membrane lipid leaflet 
is enriched with this acid, being the precursor of inflammatory eicosanoids.  
Since both T-2 and FB1 are unequivocal membrane disruptors even at the subcellular level, 
their detailed study is reasoned.  
The co-occurrence of mycotoxins makes the cytotoxicity assessment more complex, 
meanwhile Clarke et al. (9) used the EU regulation concentration limits for FB1, ochratoxin 
and aflatoxin B1 in a tertiary combination (9). In our recent study it was found that at levels of 
2 mg/kg diet T-2 toxin alone, or 10 mg/kg diet fumonisin B1 alone, and both toxins in 
combination exert hepatotoxic effect and act antagonistically onto the red cell sodium pump 
ATP breakdown capacity, T-2 markedly lowering its activity (33). However, red cell 
membrane fatty acyl chain composition was only slightly modified in the cells of the systemic 
circulation, supposing that both toxins act at the level of polychromatic erythroblasts. Here we 
tested the effects of the same toxin exposure onto the hepatic membrane and hepatic 






Materials and Methods 
Experimental design 
Pannon white littermate male rabbits weaned at the age of 35 days were caged as pairs, and 4 
groups were formed, each containing 10 animals. The animals were born, housed and treated 
at the rabbitry of the Experimental Farm of the Kaposvár University. One group was fed a 
rabbit diet complemented with 2 mg/kg T-2 toxin, another the same basal diet complemented 
with 10 mg/kg fumonisin B1 (FB1), while a further was given T-2 and FB1 in a combined 
form (2+10 mg/kg diet). The control group was fed a toxin free diet containing the same 
ingredients as the experimental ones, with the exception of fungal cultures. Feed and water 
were ad libitum offered. Bodyweight and feed intake was measured weekly, individually, and 
the entire feeding period lasted for 4 weeks. All data were recorded on individually marked 
animals, from 6 rabbits (chosen out randomly of the total of 10) in each group. 
 
Production of toxins and determination of mycotoxin content in fungal cultures and feeds 
Fumonisin B1 and T-2 toxin were produced with the application of Fusarium verticillioides 
strain MRC 826 and Fusarium sporotrichioides strain NRRL 3299, respectively (15). The 
homogenized fungal cultures contained FB1 at a concentration of 3440 mg/kg, while T-2 toxin 
concentration was 1338 mg/kg (HT-2 toxin 285 mg/kg), respectively. These fungal cultures 
were mixed into the basal feed of the experimental animals, so as to provide contaminated 
feeds with 2 mg/kg feed T-2 toxin and/or 10 mg/kg feed FB1.  
The mycotoxin concentration of the control and the experimental feeds was determined 
with LC-MS (Shimadzu, Kyoto, Japan). The limit of detection (LOD) for FB1 was 3 µg/kg, 
while for T-2 toxin it was 10 µg/kg. The diet fed to the control group did not contain 
detectable amounts of T-2 and FB1. 
 
Blood and liver tissue sampling 
Fresh venous blood was sampled into heparinized (20 IU/ml whole blood) tubes and was 
centrifuged for 10 min at 1000 g, at the end of the 4 weeks. Plasma was removed and stored at 
-70 
o
C, for sphinganine and sphingosine analysis (section 2.6.). 
 
After exsanguination whole livers were immediately dissected and weighed. Tissue 
samples of ca. 5 g were cut with scissors in a medium according to Brand et al. (5). Liver 
samples were rinsed and resuspended in 10 volumes of ice-cold medium, containing 250 mM 
sucrose, 5 mM Tris/HCl and 2 mM EGTA (pH 7.4 at 4 
o
C), then homogenized using six 
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passes of a motorized Teflon/glass Potter-Elvehjem homogenizer. All chemicals were 
purchased from Sigma-Aldrich (Schnelldorf, Germany). The homogenate was centrifuged at 
1000 g for 3 minutes, and the supernatant was centrifuged at 12000 g for further 10 minutes at 
4 
o
C. The pellet was then suspended, respun at 12000 g / 10 minutes (MLW K24 Janetzky, 





Whole tissue samples, as well as isolated mitochondria were homogenized (IKA T25 Digital 
Ultra Turrax, Staufen, Germany) in a 20-fold volume of chloroform:methanol (2:1 vol:vol) 
and total lipid content was extracted (16). Solvents were ultrapure-grade (Sigma-Aldrich, 
Schnelldorf, Germany) and 0.01 % w:v butylated hydroxytoluene was added to prevent fatty 
acid oxidation. In the frame of lipid fractionation, extracted total lipids were transferred to 
glass chromatographic columns, containing 300 mg silica gel (230-400 mesh) for 10 mg of 
lipids (24). Neutral lipids were eluted with 10 mL chloroform for the above fat amount, then 
15 mL acetone:methanol (9:1 vol:vol) was added, while 10 mL pure methanol eluted the total 
phospholipids. This latter fraction was evaporated to dryness under a nitrogen stream and was 
transmethylated with a base-catalysed NaOCH3 method (8). Fatty acid methyl-esters were 
extracted into 300 μL ultrapure n-hexane for gas chromatography. Latter was performed on a 
Shimadzu 2010 apparatus (AOC 20i automatic injector), equipped with a Phenomenex 
Zebron ZB-WAX Capillary GC column (30 m x 0.25 mm ID, 0.25 micrometer film, 
Phenomenex Inc., Torrance, CA, USA) and flame ionisation detector (FID 2×10–11). 
Characteristic operating conditions were: injector temperature: 270 °C, detector temperature: 
300 °C, helium flow: 28 cm/sec. The oven temperature was graded: from 80 to 205 °C: 2.5 
°C/min, 5 min at 205 °C, from 205 to 250 °C 10 °C/min and 5 min at 210 °C. The makeup gas 
was nitrogen. To identify individual FA, an authentic external FA standard (37 Component 
FAME Mix, Sigma-Aldrich, Cat No: CRM47885) was used. Fatty acid results were expressed 
as weight % of total fatty acid methyl esters.  
 
Unsaturation index (UI) was defined as the number of double bonds in 100 fatty acyl 
chains. From the FA results unsaturation index (UI) was calculated as: UI = [(1 x Σ 
monoenoic FA) + (2 x Σ dienoic FA) + (3 x Σ trienoic FA) + (4 x Σ tetraenoic FA) + (5 x Σ 
pentaenoic FA) + (6 x Σ hexaenoic FA)] (7). The average FA chain length was calculated 





Assessment of antioxidant defence capacity 
Lipid peroxidation was assessed in blood plasma with the determination of malondialdehyde 
(MDA) levels with 2-thiobarbituric acid method (30). The concentration of plasma reduced 
glutathione (GSH) was measured with photometry (31) and the activity of plasma glutathione 
peroxidase (GSHPx) according to Lawrence and Burk (22). 
 
Determination of the plasma sphinganine (Sa) to sphingosine (So) ratio 
Determination of Sa/So was carried out using acetonitrile (900 µl) addition to the plasma (100 
µl) and the mixture was centrifuged at 10000 rpm for 5 min and filtered through a 0.45 µm 
filter. Sphinganine and sphingosine levels were determined by LC-MS. Chromatographic 
separation was carried out using a Waters Symmetry C18 column (150 x 2.1 mm ID 5 µm; 




For the comparison of group means (bodyweight, liver weight fatty acid profile) multivariate 
analysis of variance was used (evaluating as well the interactions), with the Tukey „post hoc” 
test for the inter-group differences, preceded with the analysis of normal distribution 
(Kolmogorov-Smirnov test) (19).  
 
Ethical issues 
The experiment was carried out according to the regulations of the Hungarian Animal 




Bodyweight and liver weight 
After 4 weeks of feeding, the T-2 and the T-2+FB1 groups bodyweight was significantly 
lower, as compared to the control or even to the pure FB1 data, although the feed intake was 
not different among the groups (data not shown). The liver weight at the end of the 
experiment in the group fed T-2 fed toxin was significantly higher compared to the other 
treatment groups and reached ca. 3 times higher weight than the control (Table 1). However, 




Hepatic total phospholipids 
In Table 2, showing the total hepatic PL FA composition it is visible that all three toxin 
treatments decreased the proportion of palmitoleic acid (C16:1 n7). Arachidic acid (C20:0) 
proportion in the liver total PL fraction was increased by the combined toxin treatment (T-
2+FB1), as compared to the control. Interestingly, the unsaturation index (UI) was the highest 
in the combined toxin (T-2+FB1) exposed animals, differing significantly only from the 
control, but not from the two individual toxin treatments (T-2 and FB1 separately). A totally 
identical alteration was observed in the average fatty acyl chain length (ACL). Altogether, 
neither the separated nor the combined mycotoxin treatments induced drastic fatty acid 
compositional alteration in the hepatic total phospholipids. 
 
Liver mitochondrial phospholipids 
In the isolated mitochondria, the membrane lipids revealed to be more prone towards the 
mycotoxin exposure. Table 3 summarizes the results concerning the alterations of the 
mitochondrial membrane PL FA composition. Margaric acid (C17:0) proportion was 
decreased in both separated toxin treatments, as compared to the combined setting. Oleic acid 
(C18:1 n9) (a major membrane component of the PL fraction) proportion was significantly 
increased by FB1. Arachidonic acid (C20:4 n6) was decreased in the FB1 group, as compared 
to the control and the binary mixture treatment. Docosapentaenoic acid (C22:5 n3) proportion 
was decreased significantly in both separate treatments, as compared to the combined group, 
but not differing from the control. 
In the calculated FA data, total monounsaturation (MUFA) was significantly higher in the 
FB1 group, as compared to the control. A fully opposite result was found for the total 
polyunsaturation, while the total n3 FA proportion was increased (on the expense of the total 
n6 FAs). 
 
Antioxidant defense capacity 
In the blood plasma the concentration of reduced glutathione was the highest in the control, 
significantly differing from all toxin treated groups. Identical finding was detected by 
glutathione-peroxidase, but no alteration was detected in the plasma malondialdehyde 





Plasma sphinganine (Sa) to sphingosine (So) ratio 
After 4 weeks of mycotoxin exposure, plasma sphinganine/sphingosine ratio was increased by 
FB1 alone, but to a lesser extent, even in combination with T-2 toxin, while T-2 toxin alone 





Bodyweight and liver weight 
The toxin exposure lasted for 28 days until the animals reached the approximate Hungarian 
conventional slaughter weight. T-2 alone or in combination (with FB1) appeared as a growth 
depressing factor. Meanwhile fumonisin B1 was administered in relatively high dose (10 mg / 
kg feed), as a single toxin it had no detectable effect either on bodyweight or on liver weight, 
as compared to the control.  
In contrast, T-2 toxin led to a marked growth depression, independently of the 
administration type (single toxin or co-occurring with FB1). In a recent study (34) the <0.02 
mg/kg bodyweight/day T-2 concentration value was defined as the no observed adverse effect 
level (NOAEL) for rabbit bucks. This present treatment was exceeding this value (ca. 0.96 
mg/kg bodyweigt/day), leading to well established compromised growth. The three-fold 
increased liver weight (as in this study) is a well-known consequence even in acute T-2 
toxicosis in rabbits, accompanied by centrolobular dystrophy (34). (The most remarkable 
pathological findings included enlarged, friable, pale, yellowish liver, with spot-like necrotic 
areas (unpublished observations). The results clearly refer to the hypothesis that T-2 toxin, as 
a type A trichothecene with its characteristic hydroxyl and ester groups (thus being 
amphipatic (27)) exerts a direct hepatotoxic effect, unequivocally supporting the hypothesis 
that it – due to its molecular characteristics – effectively crosses the hepatocellular membrane 
(i.e. the amphipathic PLs) (9). 
 
Fatty acid composition 
 
Hepatic total phospholipids 
In spite of the dramatically enlarged liver, T-2 toxin alone was less affecting hepatic total 
phospholipid fatty acyl chain composition. There was no single fatty acid of which T-2 toxin 
clearly altered the proportion, as compared to any of the other (combined or single) toxin 
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treatments. Altogether one monounsaturated (C16:1 n7, palmitoleic acid), one odd chain 
(C17:0, margaric acid) fatty acid showed altered proportion in the liver total PLs of the T-2 
toxin group, as compared to the control. It was interesting that even on the calculated fatty 
acid parameters, T-2 toxin had only a slight effect, not differing significantly from the control, 
even not in the unsaturation index value (UI).  
The only hint that FB1 alters hepatic (microsomal) membrane lipid palmitoleic acid 
proportion has been published by Gelderblom et al. (17). These authors described a disturbed 
microsomal lipid metabolism with increased delta-9 desaturase activity (not proven in the 
hepatic total PLs in our study), but it has to be added that in the cited study 100 mg/kg feed 
FB1 was fed to rats (carcinogenic level). Interestingly, the inhibition of ceramide synthase by 
FB1 was not reflected in the microsomal membrane lipids (17), even at this high-dose 
treatment. 
As the first level interpretation, for FB1 identical results were found to that of T-2 toxin in 
the liver total PLs. However, as compared to the rat microsomal membranes, FB1 alone was 
not a very potent modulator/disruptor of hepatic total PL FA composition, neither inducing 
liver weight alteration. 
In contrast, the combined application (T-2+FB1) of the two mycotoxins, as compared to the 
control or even the individual toxin exposures was “effective”, in that this treatment reduced 
the C16:1 n7 proportion (but did not perturb delta-9 desaturation significantly!) and slight, but 
significant increase was found for arachidic acid, the unsaturation index (UI) and the average 
fatty acyl chain length (ACL). In the multivariate statistical model, there was no interaction 
for ACL between the treatments (i.e. T-2 and FB1), but for C16:1 n7, C20:0 and UI the 
interaction (i.e. T-2 x FB1) of the two toxins was significant at the level of P<0.001. We thus 
suppose a synergism in these cases, the two fusariotoxins augmenting their common effects 
upon the latter FAs and unsaturation.  
Comparing our results to literature data, it must be emphasized that total hepatic 
phospholipids have not yet been analyzed as the targets of combined T-2+FB1 toxins. It thus 
seems that at the moderately high levels neither T-2 toxin, nor FB1 are hepatocellular 
membrane disruptors in the leporine model, when the exposure is relatively short (4 weeks), 
but T-2 toxin provides a rather effective translocation across the hepatocellular membrane 






Liver mitochondrial phospholipids 
In isolated mitochondria, the PLs were more strongly modified by the mycotoxin exposure. 
Margaric acid (C17:0) proportion was decreased by both individual toxin treatments (T-2 and 
FB1) as compared to the combined setting, while the combined treatment increased its 
proportion (but was not different from the control). Their statistical interaction in the 
multivariate model was significant (P<0.001), suggesting a synergistic effect. In rabbit tissue 
membranes, margaric acid abundance is clearly depending on two factors. Once, odd chain 
FAs are exclusively synthesized by the gut microflora, and as second, odd chain saturated 
FAs are peripherally (position sn-1) located in phosphatidylcholine and are primary targets of 
beta- oxidation (being quasi equivalent with paired chain saturated FAs in this respect), when 
hydrolyzed by the most abundant PLase A2 (23). The enzymatic cleavage of an odd chain 
saturated FA at position sn-1 may be a part of the Lands mechanism (10, 21), a means to 
regulate membrane fluidity via the modification of the glycerolipid FA side chain 
combinations.  
Oleic acid (C18:1 n9) proportion was significantly increased only in the FB1 group, and in 
the combined treatment the difference was not significant among individual treatments and 
control. In our earlier study (33), in the erythrocyte membrane, oleic acid provided the highest 
proportion in the combined treatment. This partly agrees with the results of Gelderblom et al. 
(17), who reported that FB1 at 100 mg/kg feed induced delta-9 desaturase activation and 
increased membrane monounsaturation. It is important to add that we only fed 4 weeks of this 
concentration, but it is a necessary addition that rabbits perform coecotrophy (33), while rats 
coprophagy (17); this means that the exact toxin (or mycotoxin metabolite) concentration at 
the site of action (liver) is with the highest probability higher than that in the feed. The reason 
why FB1 seems to be a more potent modulator of delta-9 desaturation may be due to the lower 
stability of T-2 toxin, which is very quickly, enzymatically hydrolized to HT-2 (9). 
Meanwhile FB1 is a more stable molecule and there are further factors to be considered in 
rabbits. In monogastric animals (piglets), the accumulative absorption of fumonisin B1 is only 
ca. 4% (15). However, as a result of coecotrophy in rabbit, the accumulative absorption may 
increase, while the hidden proportion, occurring in a matrix associated form may be as well 
liberated by the digestive enzymes (during the multiplied uptake via coecotrophy), leading 
ultimately to a higher toxin exposure than determined analytically from the food (34).  
 
The biological background to decrease polyunsaturation in parallel to increase 
monounsaturation is a means to maintain membrane fluidity by decreasing the sensitivity 
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towards lipid peroxidation (29). Although it was not directly measured from the liver, in the 
blood plasma the concentration of reduced glutathione was the highest in the control, 
significantly differing from all other toxin treatments, referring to an effective scavenger role 
against the emerging reactive oxygen substances (Figure 1). The same alteration was found 
for glutathione-peroxidase, but no alteration was detected in the plasma malondialdehyde 
concentration. MDA is formed in the terminal phase of lipid peroxidation from FAs having at 
least three double bonds, and is strongly cytotoxic (23). In this study the extent of lipid 
peroxidation, as assessed from the blood plasma was maintained at a relatively low level.  
 
It thus seems that the cross-membrane transport has a more widespread effect, even 
detectable in the systemic circulation (4), as published for T-2 (broiler chickens) and for FB1 
in pigs (20). The role of GSHPx is to “up-oxidate” the reduced glutathione moiety. Indeed, 
our results supported this fact, namely GSHPx was likewise in a more saturated enzymatic 
phase, as compared to the control.  
 
Mitochondrial membrane arachidonic acid (C20:4 n6) proportion decreased only in the 
FB1 group, as compared to the control and the binary mixture treatment. In the biological 
membranes, primarily in phospholipids, arachidonic acid is the root component of the 
eicosanoids, liberated via the activity of phospholipase A2. Although different cell organelles 
and lipid fractions react to FB1 induced stimuli divergently, Burger et al. (6) reported 
supportive results in that FB1 was liberated form the PC fraction, augmenting prostaglandin 
E2 series synthesis, inducing sustaining cell proliferation (2). The further fact to take into 
account is that impaired arachidonic acid metabolism, in particular its proportional decrease 
in the PC fraction has been implied as a growth stimulus for hepatocellular nodules (1).  
 
Docosapentaenoic acid (C22:5 n3) proportion was decreased significantly in both separate 
treatments, as compared to the combined group, but not differing from the control. According 
to Abel et al. (2001), the proportional decrease of C20-C22 FAs is a factor to control/improve 
antioxidant properties. This is underpinned with the fact that meanwhile the pentaenoic FA 
proportion and the monounsaturation were increased and there is a ca. 4-fold sensitivity 
difference in the peroxidation sensitivity between oleic and docosapentaenoic acids (18). In 
the calculated FA data total monounsaturation (MUFA) was significantly higher in the FB1 
group, as compared to the control. A fully opposite result was found for the total 
polyunsaturation, while the total n3 FA proportion increased. 
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Summarizing the above findings in the mitochondrial fatty acid composition, Burger et al. 
(6) reported that the modified fatty acid profile may be coupled with an altered growth pattern 
of FB1 intoxicated hepatocytes, including as well the perturbation of the ceramide synthesis. 
Indeed, we did not measure hepatocellular, but only plasma sphinganine/sphingosine ratio, it 
was found that FB1 alone, but to a lesser extent, even in combination with T-2 is able to 
markedly increase this ratio, while T-2 did not influence the plasma Sa/So ratio (Figure 2). 
 
In conclusion, it was found that at the pre-defined mycotoxin concentration values young 
rabbits are more prone towards T-2 toxin administration, which slightly alters hepatic plasma 
and mitochondrial membrane composition. When T-2 toxin was fed in combination with FB1, 
synergistic effects was proven for saturated (C16:0, C17:0, C20:0) and monounsaturated fatty 
acids. All toxin treatments induced lipid peroxidation and activated the antioxidant defense 
(GSHPx). Fumonisin was moreover proven to perturb membrane ceramide homeostasis, even 
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Table 1. Liver and bodyweight of the four experimental groups (means ± SD) 
group 
liver weight (g)   bodyweight (g; day 60)   
mean  ± SD   mean  ± SD   
T-2 219.2 ± 3.37 b 2280 ± 82.6 A 
FB1 75.8 ± 4.35 ab 2695 ± 84.1 B 
T-2+FB1 72.8 ± 4.35 a 2221 ± 81.7 A 
Control 91 ± 8.39 ab 2653 ± 69 B 

















Table 2. The total hepatic phospholipid fatty acid composition of the control and the toxin 








liver PL Mean ± SD 
 
 Mean ± SD 
 
 Mean ± SD 
 
 Mean ± SD   
C14:0 0.06 ± 0.01  0.08 ± 0.02  0.07 ± 0.01  0.12 ± 0.09  
C15:0 0.19 ± 0.03  0.17 ± 0.04  0.20 ± 0.02  0.17 ± 0.04  
C16:0 19.1 ± 0.97  19.2 ± 1.33  17.5 ± 1.73  20.3 ± 2.81  
C16:1 n7 0.39 ± 0.13 a 0.45 ± 0.05 
a
 0.31 ± 0.14 
a
 0.66 ± 0.22 
b
 
C17:0 0.85 ± 0.12 b 0.72 ± 0.14 
ab
 0.91 ± 0.07 
b
 0.63 ± 0.11 
a
 
C18:0 24.4 ± 0.96  23.1 ± 1.08  24.1 ± 1.88  22.5 ± 1.64  
C18:1 n9c 13.5 ± 2.20  15.2 ± 0.91  13.8 ± 1.13  15.3 ± 1.43  
C18:2 n6c 29.2 ± 2.47  29.1 ± 0.74  29.1 ± 0.07  28.4 ± 2.38  
C18:3 n6c 0.09 ± 0.09  0.04 ± 0.01  0.05 ± 0.01  0.09 ± 0.08  
C18:3 n3 0.50 ± 0.06  0.55 ± 0.09  0.51 ± 0.03  0.49 ± 0.14  
C20:0 0.04 ± 0.00 a 0.04 ± 0.00 
a
 0.05 ± 0.01 
b
 0.04 ± 0.01 
a
 
C20:1 n9 0.27 ± 0.05  0.32 ± 0.16  0.35 ± 0.15  0.31 ± 0.12  
C20:2 n6 0.68 ± 0.14  0.89 ± 0.17  0.90 ± 0.29  0.75 ± 0.26  
C22:0 0.42 ± 0.35  0.27 ± 0.06  0.34 ± 0.16  0.38 ± 0.22  
C20:3 n6 0.93 ± 0.27  0.88 ± 0.11  1.07 ± 0.21  0.95 ± 0.30  
C20:3 n3 0.03 ± 0.01  0.03 ± 0.01  0.04 ± 0.03  0.03 ± 0.01  
C20:4 n6 7.96 ± 0.48  7.40 ± 0.98  9.06 ± 1.66  7.41 ± 0.55  
C22:5 n3 0.25 ± 0.04  0.23 ± 0.06  0.31 ± 0.07  0.24 ± 0.05  
C22:6 n3 0.17 ± 0.04   0.15 ± 0.05 
 
 0.19 ± 0.06 
 
 0.17 ± 0.05 
 
 
saturated 45.0 ± 1.43 
 
43.6 ± 1.05 
 
43.2 ± 1.11 
 
44.1 ± 1.48 
 
monoenoic 14.1 ± 2.31 
 
16.0 ± 1.02 
 
14.5 ± 1.42 
 
16.3 ± 1.66 
 
PUFA 39.8 ± 2.67 
 
39.3 ± 1.05 
 
41.2 ± 1.72 
 
38. 6 ± 2.73 
 
n3 0.95 ± 0.13 
 
0.96 ± 0.17 
 
1.05 ± 0.11 
 
0.92 ± 0.17 
 
n6 38.9 ± 2.60 
 
38.3 ± 0.93 
 
40.2 ± 1.63 
 
37.6 ± 2.70 
 
n6/n3 41.2 ± 4.26 
 
40.8 ± 6.17 
 
38.7 ± 3.41 
 
42.0 ± 6.58 
 
UI 112.7 ± 3.90 
ab
 112.22 ± 3.40 
ab
 118.39 ± 6.09 
b
 111.1 ± 4.88 
a
 
ACL 17.66 ± 0.04 
ab
 17.64 ± 0.05 
ab
 17.70 ± 0.10 
b
 17.62 ± 0.06 
a
 





Table 3. The hepatic mitochondrial phospholipid fatty acid composition of the control and the 








liver mit. PL Mean ± SD 
 
 Mean ± SD 
 
 Mean ± SD 
 
 Mean ± SD 
 
 
C14:0 0.21 ± 0.19 
 
0.28 ± 0.12 
 
0.15 ± 0.10 
 
0.22 ± 0.16 
 
C15:0 0.20 ± 0.10 
 
0.21 ± 0.08 
 
0.27 ± 0.04 
 
0.24 ± 0.06 
 
C16:0 20.6 ± 2.03 
 
21.0 ± 3.73 
 
18.2 ± 1.24 
 
18.4 ± 1.78 
 
C16:1 n7 1.27 ± 0.46 
 
1.20 ± 0.17 
 
0.75 ± 0.23 
 
1.13 ± 0.43 
 
C17:0 0.61 ± 0.18 
a
 0.60 ± 0.16 
a
 0.92 ± 0.15 
b
 0.79 ± 0.17 
ab
 
C18:0 17.3 ± 1.05 
 
16.5 ± 1.00 
 
18.3 ± 4.39 
 
16.7 ± 4.60 
 
C18:1 n9c 23.4 ± 4.68 
ab
 26.8 ± 1.56 
b
 20.3 ± 3.63 
ab
 19.1 ± 4.99 
a
 
C18:2 n6c 25.6 ± 5.63 
 
22.0 ± 6.05 
 
28.7 ± 4.24 
 
30.3 ± 3.78 
 
C18:3n6 0.19 ± 0.06 
 
0.38 ± 0.17 
 
0.09 ± 0.05 
 
0.19 ± 0.24 
 
C18:3n3 1.61 ± 0.80 
 
2.04 ± 0.60 
 
1.23 ± 0.40 
 
1.92 ± 1.21 
 
C20:0 0.08 ± 0.02 
 
0.09 ± 0.02 
 
0.08 ± 0.01 
 
0.08 ± 0.03 
 
C20:1 0.70 ± 0.37 
 
0.86 ± 0.59 
 
0.51 ± 0.18 
 
0.46 ± 0.12 
 
C20:3n6 0.90 ± 0.44 
 
0.80 ± 0.37 
 
1.39 ± 0.31 
 
1.28 ± 0.45 
 
C20:3n3 0.23 ± 0.04 
ab
 0.27 ± 0.20 
b
 0.07 ± 0.03 
ab
 0.23 ± 0.11 
ab
 
C20:4n6 4.83 ± 1.05 
ab
 4.04 ± 0.34 
a
 6.39 ± 1.58 
b
 6.43 ± 1.32 
b
 
C22:5n3 0.19 ± 0.04 
a
 0.18 ± 0.02 
a
 0.28 ± 0.05 
b
 0.25 ± 0.06 
ab
 
C22:6n3 0.83 ± 0.34 
 
 1.41 ± 1.15 
 
 0.63 ± 0.53 
 
 0.55 ± 0.24 
 
 
saturated 39.0 ± 1.57 
 
38.6 ± 4.12 
 
37.9 ± 4.50 
 
36.4 ± 4.23 
 
monoenoic 23.5 ± 4.34 
ab
 28.7 ± 1.37 
b
 21.7 ± 3.66 
ab
 20.8 ± 4.97 
a
 
PUFA 34.4 ± 5.69 
ab
 31.1 ± 5.43 
a
 38.7 ± 4.87 
ab
 41.2 ± 4.55 
b
 
n3 2.85 ± 1.03 
ab
 3.90 ± 0.82 
b
 2.20 ± 0.44 
a
 2.95 ± 1.55 
a
 
n6 31.6 ± 6.55 
ab
 27.2 ± 6.04 
a
 36.5 ± 5.15 
ab
 38.2 ± 4.87 
b
 
n6/n3 12.8 ± 6.71 
 
7.37 ± 2.53 
 
17.6 ± 6.09 
 
16.9 ± 11.5 
 
UI 102.9 ± 20.0 
 
108.7 ± 5.44 
 
118.0 ± 9.68 
 
122.5 ± 9.39 
 
ACL 17.5 ± 0.14 
 
 17.5 ± 0.17 
 
 17.5 ± 0.13 
 
 17.5 ± 0.10 
 
 








Figure 1. The extent of antioxidant capacity (GSH, GSHPx) and the concentration of the 
ultimate lipid peroxidation product, malondialdehyde, in the blood plasma of the rabbits 
(means ± SD) 
 
 
Figure 2. The plasma sphinganine to sphingosine ratio after four weeks of feeding FB1, T-2 
toxin, and T-2+FB1 as compared to the control (means ± SD) 
 
